Steering Committee Meeting - 07/2009
From LipidomicsWiki
(Difference between revisions)
Line 25: | Line 25: | ||
| 08:40 - 08:50 | | 08:40 - 08:50 | ||
| Scientific Advisory Committee Prof. M. Wenk | | Scientific Advisory Committee Prof. M. Wenk | ||
- | | | + | | <br> |
|- | |- | ||
| 08:50 - 09:00 | | 08:50 - 09:00 | ||
| Scientific Advisory Committee Prof. E. Dennis | | Scientific Advisory Committee Prof. E. Dennis | ||
- | | | + | | <br> |
|- | |- | ||
| 09:00 - 09:10 | | 09:00 - 09:10 | ||
| Scientific Advisory Committee Prof. D. Brasaemle | | Scientific Advisory Committee Prof. D. Brasaemle | ||
- | | | + | | <br> |
|- | |- | ||
| 09:10 - 09:20 | | 09:10 - 09:20 | ||
| Audit and Ethics Committee N. N. (no confirmation received) | | Audit and Ethics Committee N. N. (no confirmation received) | ||
- | | | + | | <br> |
|- | |- | ||
| 09:20 - 09:30 | | 09:20 - 09:30 | ||
| Audit and Ethics Committee N. N. (no confirmation received) | | Audit and Ethics Committee N. N. (no confirmation received) | ||
- | | | + | | <br> |
|- | |- | ||
| colspan="3" | Work package and deliverable-orientated presentations | | colspan="3" | Work package and deliverable-orientated presentations | ||
|- | |- | ||
- | | | + | | <br> |
| WP 1 (Chair: Prof. G. Schmitz) | | WP 1 (Chair: Prof. G. Schmitz) | ||
| Scientific management | | Scientific management | ||
|- | |- | ||
- | | | + | | <br> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
| WP 2, together with TF I - IV (Chair: Prof. C. Thiele) | | WP 2, together with TF I - IV (Chair: Prof. C. Thiele) | ||
| Enabling technologies | | Enabling technologies | ||
Line 65: | Line 57: | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. M. Grandl (P01) | | Dr. M. Grandl (P01) | ||
| High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages | | High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. G. Liebisch (P01) | | Dr. G. Liebisch (P01) | ||
| Analysis of glycerophosphoplipid species | | Analysis of glycerophosphoplipid species | ||
|- | |- | ||
- | | | + | | <br> |
| M. Scherer (P01) | | M. Scherer (P01) | ||
| Analysis of sphingolipid species | | Analysis of sphingolipid species | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. J. Hansen (P01) | | Dr. J. Hansen (P01) | ||
| Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array | | Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array | ||
|- | |- | ||
- | | | + | | <br> |
| WP 3, together with TF V (Chair: Prof. C. Wolfrum) | | WP 3, together with TF V (Chair: Prof. C. Wolfrum) | ||
| Mouse models of liver and adipose lipid droplet processing | | Mouse models of liver and adipose lipid droplet processing | ||
|- | |- | ||
- | | | + | | <br> |
| N. N. N. N: | | N. N. N. N: | ||
| Rühl-Kooperation-Liver/LXR ATP10D and liver | | Rühl-Kooperation-Liver/LXR ATP10D and liver | ||
|- | |- | ||
- | | | + | | <br> |
| WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam) | | WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam) | ||
| Dysregulation of liver and adipose lipid droplet processing in human diseases | | Dysregulation of liver and adipose lipid droplet processing in human diseases | ||
Line 97: | Line 89: | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. V. Tarabin (P01) | | Dr. V. Tarabin (P01) | ||
<br> | <br> | ||
Line 103: | Line 95: | ||
| Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation | | Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. J. Ecker (P01) | | Dr. J. Ecker (P01) | ||
| Metabolic changes of lipid metabolism during adipocyte differentiation | | Metabolic changes of lipid metabolism during adipocyte differentiation | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. C. Hellerbrand / Dr. T. Weiss (P01) | | Dr. C. Hellerbrand / Dr. T. Weiss (P01) | ||
<br> | <br> | ||
Line 113: | Line 105: | ||
| Influence of palmitate and ω3/ ω6-fatty acids on human liver cells | | Influence of palmitate and ω3/ ω6-fatty acids on human liver cells | ||
|- | |- | ||
- | | | + | | <br> |
| colspan="2" | Coffee Break | | colspan="2" | Coffee Break | ||
|- | |- | ||
- | | | + | | <br> |
| WP 5 (Chair: Prof. Schmitz) | | WP 5 (Chair: Prof. Schmitz) | ||
| Lipid droplets and lipid bodies in human macrophages and leukocytes | | Lipid droplets and lipid bodies in human macrophages and leukocytes | ||
Line 124: | Line 116: | ||
|- | |- | ||
- | | | + | | <br> |
| K. Rübsaamen (born Leidl) (P01) | | K. Rübsaamen (born Leidl) (P01) | ||
| Lipidomic analysis of monocytes and granulocytes | | Lipidomic analysis of monocytes and granulocytes | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. A. Sigrüner (P01) | | Dr. A. Sigrüner (P01) | ||
| Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes | | Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. J. Ecker (P01) | | Dr. J. Ecker (P01) | ||
| The role of SREBP-1c mediated induction of lipid metabolism for macrophage development | | The role of SREBP-1c mediated induction of lipid metabolism for macrophage development | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. Margot Grandl (P01) | | Dr. Margot Grandl (P01) | ||
| Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment. | | Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment. | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. K. Leuthäuser-Jaschinski (P01) | | Dr. K. Leuthäuser-Jaschinski (P01) | ||
| Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages | | Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01) | | Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01) | ||
| N/N | | N/N | ||
|- | |- | ||
- | | | + | | <br> |
| N/N | | N/N | ||
| Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics | | Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics | ||
|- | |- | ||
- | | | + | | <br> |
| WP 6 (Chair: Prof. Sandhoff) | | WP 6 (Chair: Prof. Sandhoff) | ||
| Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies | | Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies | ||
|- | |- | ||
- | | | + | | bgcolor="#ffffcc" | <br> |
- | | | + | | bgcolor="#ffffcc" | Lunch |
- | | | + | |
|- | |- | ||
- | | | + | | <br> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
| WP 7, together with TF VIII (Chair: Dr. L. Martens) | | WP 7, together with TF VIII (Chair: Dr. L. Martens) | ||
| Bioinformatics | | Bioinformatics | ||
|- | |- | ||
- | | | + | | <br> |
| Dr. P. Ugocsai (P01) | | Dr. P. Ugocsai (P01) | ||
| Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study | | Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study | ||
|- | |- | ||
- | | | + | | <br> |
| J. Koopmann (P01) | | J. Koopmann (P01) | ||
| Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study | | Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study | ||
|- | |- | ||
- | | | + | | <br> |
| WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć) | | WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć) | ||
| Dissemination and training | | Dissemination and training | ||
Line 187: | Line 171: | ||
|- | |- | ||
- | | | + | | <br> |
| Coffee Break | | Coffee Break | ||
- | | | + | | <br> |
|} | |} | ||
Line 198: | Line 182: | ||
{| class="prettytable" | {| class="prettytable" | ||
|- | |- | ||
- | | | + | | <br> |
| colspan="2" | Tuesday, 14.07.2009 | | colspan="2" | Tuesday, 14.07.2009 | ||
|- | |- | ||
- | | | + | | <br> |
| colspan="2" | Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee | | colspan="2" | Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee | ||
<br> | <br> | ||
Line 208: | Line 192: | ||
|- | |- | ||
- | | | + | | <br> |
| Scientific Advisory Committee | | Scientific Advisory Committee | ||
Prof. M. Wenk | Prof. M. Wenk | ||
- | | | + | | <br> |
|- | |- | ||
- | | | + | | <br> |
- | | Scientific Advisory Committee | + | | colspan="2" | Scientific Advisory Committee <br> |
- | + | ||
- | + | ||
- | + | ||
|- | |- | ||
- | | | + | | <br> |
- | | Scientific Advisory Committee | + | | colspan="2" | Scientific Advisory Committee <br> |
- | + | ||
- | + | ||
- | + | ||
|- | |- | ||
- | | | + | | <br> |
| colspan="2" | Audit and Ethics Committee <br> | | colspan="2" | Audit and Ethics Committee <br> | ||
|- | |- | ||
- | | | + | | <br> |
| colspan="2" | Audit and Ethics Committee <br> | | colspan="2" | Audit and Ethics Committee <br> | ||
|- | |- | ||
- | | | + | | <br> |
| colspan="2" | Coffee break | | colspan="2" | Coffee break | ||
|- | |- |
Revision as of 16:11, 11 May 2009
Date
1st Annual Steering Committee Meeting Regensburg, 13th - 14th July 2009
Venue
University Hospital Regensburg Franz-Josef-Strauss-Allee 11D-93053 RegensburgGermany
Phone: +49-941-944-6203
Time | Monday, 13.07.2009 | |
---|---|---|
08:30 - 08:40 | Introduction / Welcome (Prof. G. Schmitz, Regensburg) | |
Presentations of the LipidomicNet Scientific Advisory Committee and Audit and Ethics Committee | ||
08:40 - 08:50 | Scientific Advisory Committee Prof. M. Wenk | |
08:50 - 09:00 | Scientific Advisory Committee Prof. E. Dennis | |
09:00 - 09:10 | Scientific Advisory Committee Prof. D. Brasaemle | |
09:10 - 09:20 | Audit and Ethics Committee N. N. (no confirmation received) | |
09:20 - 09:30 | Audit and Ethics Committee N. N. (no confirmation received) | |
Work package and deliverable-orientated presentations | ||
| WP 1 (Chair: Prof. G. Schmitz) | Scientific management |
| WP 2, together with TF I - IV (Chair: Prof. C. Thiele) | Enabling technologies
|
| Dr. M. Grandl (P01) | High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages |
| Dr. G. Liebisch (P01) | Analysis of glycerophosphoplipid species |
| M. Scherer (P01) | Analysis of sphingolipid species |
| Dr. J. Hansen (P01) | Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array |
| WP 3, together with TF V (Chair: Prof. C. Wolfrum) | Mouse models of liver and adipose lipid droplet processing |
| N. N. N. N: | Rühl-Kooperation-Liver/LXR ATP10D and liver |
| WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam) | Dysregulation of liver and adipose lipid droplet processing in human diseases
|
| Dr. V. Tarabin (P01)
| Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation |
| Dr. J. Ecker (P01) | Metabolic changes of lipid metabolism during adipocyte differentiation |
| Dr. C. Hellerbrand / Dr. T. Weiss (P01)
| Influence of palmitate and ω3/ ω6-fatty acids on human liver cells |
| Coffee Break | |
| WP 5 (Chair: Prof. Schmitz) | Lipid droplets and lipid bodies in human macrophages and leukocytes
|
| K. Rübsaamen (born Leidl) (P01) | Lipidomic analysis of monocytes and granulocytes |
| Dr. A. Sigrüner (P01) | Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes |
| Dr. J. Ecker (P01) | The role of SREBP-1c mediated induction of lipid metabolism for macrophage development |
| Dr. Margot Grandl (P01) | Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment. |
| Dr. K. Leuthäuser-Jaschinski (P01) | Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages |
| Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01) | N/N |
| N/N | Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics |
| WP 6 (Chair: Prof. Sandhoff) | Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies |
| Lunch | |
| WP 7, together with TF VIII (Chair: Dr. L. Martens) | Bioinformatics |
| Dr. P. Ugocsai (P01) | Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study |
| J. Koopmann (P01) | Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study |
| WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć) | Dissemination and training
|
| Coffee Break | |
| Tuesday, 14.07.2009 | |
| Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee
| |
| Scientific Advisory Committee
Prof. M. Wenk | |
| Scientific Advisory Committee | |
| Scientific Advisory Committee | |
| Audit and Ethics Committee | |
| Audit and Ethics Committee | |
| Coffee break | |
13:00 | End of meeting |